Tsubota Laboratory Inc
TSE:4890
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tsubota Laboratory Inc
Free Cash Flow
Tsubota Laboratory Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tsubota Laboratory Inc
TSE:4890
|
Free Cash Flow
-¥331.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Free Cash Flow
¥748.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
20%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Free Cash Flow
-¥53.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Free Cash Flow
¥261.9B
|
CAGR 3-Years
36%
|
CAGR 5-Years
14%
|
CAGR 10-Years
4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Free Cash Flow
¥274.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Free Cash Flow
¥380.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Tsubota Laboratory Inc
Glance View
Tsubota Laboratory Inc is a JP-based company operating in Pharmaceuticals industry. The company is headquartered in Shinjuku, Tokyo-To and currently employs 9 full-time employees. The company went IPO on 2022-06-23. Tsubota Laboratory Inc is a Japan-based company mainly engaged in the research and development of new treatments for myopia, dry eye, and presbyopia. The firm operates with a B2B business model. The model generates revenue from lump-sum payments under joint research and development agreements and licensing agreements with partner companies, milestone payments, and royalties under post-commercialization (post-launch) loyalty agreements and creates new value by investing the profits in the new research. The firm is also engaged in the research and development of products for adults that treat depression and dementia, improve sleep and increase concentration.
See Also
What is Tsubota Laboratory Inc's Free Cash Flow?
Free Cash Flow
-331.8m
JPY
Based on the financial report for Mar 31, 2025, Tsubota Laboratory Inc's Free Cash Flow amounts to -331.8m JPY.
What is Tsubota Laboratory Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
-6%
Over the last year, the Free Cash Flow growth was -6%.
